Plain-English translation of NCT07318597 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called to see if it can help people with pulmonary arterial hypertension—a serious condition where blood pressure in the lungs becomes dangerously high. Researchers want to know if the medication is safe and effective when used alongside the other PAH medicines you're already taking. The study will also track how much of the medication stays in your blood and whether your body's immune system reacts to it.
Current PAH treatments help many patients, but doctors are looking for additional options that might work even better, especially for people whose symptoms are not fully controlled with existing medicines. This trial aims to find out if this new treatment could give patients another tool to manage their condition.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to receive either the new medication or a placebo (dummy treatment) while continuing your current PAH medicines. You'll visit the study site regularly for blood tests, heart function assessments, and walk tests to measure how you're doing. The study includes an initial treatment phase followed by an optional longer-term extension phase where eligible participants can continue receiving the medication.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
United States
Australia
Belgium